Viatris and two other drugmakers recently issued notices to 340B covered entities.

Viatris, Amgen, GSK Announce 340B Refunds; Amgen Issues NDC Change

May 20, 2025 Bella Czajkowski, National Correspondent Views

Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!